JP Morgan Chase & Co’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.45M | Sell |
|
|||||
|
2025
Q2 | $3.83M | Buy |
|
|||||
|
2025
Q1 | $4.24M | Sell |
|
|||||
|
2024
Q4 | $6.67M | Buy |
|
|||||
|
2024
Q3 | $1.76M | Buy |
|
|||||
|
2024
Q2 | $564K | Sell |
|
|||||
|
2024
Q1 | $765K | Buy |
|
|||||
|
2023
Q4 | $670K | Sell |
|
|||||
|
2023
Q3 | $578K | Sell |
|
|||||
|
2023
Q2 | $599K | Buy |
|
|||||
|
2023
Q1 | $308K | Buy |
|
|||||
|
2022
Q4 | $192K | Buy |
|
|||||
|
2022
Q3 | $186K | Buy |
|
|||||
|
2022
Q2 | $219K | Sell |
|
|||||
|
2022
Q1 | $368K | Buy |
|
|||||
|
2021
Q4 | $405K | Sell |
|
|||||
|
2021
Q3 | $521K | Buy |
|
|||||
|
2021
Q2 | $855K | Buy |
|
|||||
|
2021
Q1 | $31K | Sell |
|
|||||
|
2020
Q4 | $114K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.18M | Buy |
|
|||||
|
2018
Q2 | $3.12M | Buy |
|
|||||
|
2018
Q1 | $398K | Sell |
|
|||||
|
2017
Q4 | $853K | Buy |
|
|||||
|
2017
Q3 | $552K | Sell |
|
|||||
|
2017
Q2 | $939K | Sell |
|
|||||
|
2017
Q1 | $1.3M | Buy |
|
|||||
|
2016
Q4 | $15K | Buy |
|
|||||
|
2016
Q3 | $12K | Buy |
|
|||||
|
2016
Q2 | $7K | Buy |
|
|||||
|
2016
Q1 | $1K | Hold |
|
|||||
|
2015
Q4 | $1K | Buy |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $20.7M | Sell |
|
|||||
|
2014
Q3 | $21M | Sell |
|
|||||
|
2014
Q2 | $20.9M | Buy |
|
|||||
|
2014
Q1 | $12.5M | Buy |
|
|||||
|
2013
Q4 | $10.2M | Buy |
|
|||||
|
2013
Q3 | $49K | Sell |
|
|||||
|
2013
Q2 | $577K | Buy |
|